FDA approves brain stem cell transplant

10/21/2005 | San Francisco Chronicle · Wall Street Journal, The

FDA granted permission to doctors at Stanford University Medical Center to transplant immature neural cells into the brains of six children with Batten disease, a degenerative, fatal illness. If approved by an internal Stanford review board, the transplant aims to have the immature cells grow into mature brain cells capable of producing a missing enzyme, a treatment that has shown promise in Batten-afflicted mice. Stem Cells, the biotech firm that developed the treatment, hopes the trial will demonstrate the efficacy and safety of the transplant.

View Full Article in:

San Francisco Chronicle · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR